Targeted IV therapy for the detoxification of heavy metal body burden. This therapy involves initial testing followed by a series of chelation infusions. Research supports its profound benefit in cases of high blood pressure, coronary artery disease, chronic kidney failure, and type 2 diabetes mellitus. Individuals who have had a heart attack in the past and also have diabetes will have a nearly 40 percent reduced risk of a second heart attack after chelation therapy based on a recent large research study.